AstraZeneca and Oxford University reported success in their vaccine trial, after Moderna Inc and Pfizer Inc with Germany's BioNTech SE. This comes after a U.S. government official said that the first vaccines could be given to U.S. healthcare workers and others recommended by mid-December. Britain is also hoping to start vaccination mid-December.
With six sessions remaining, November 2020 may well go down in history as one of the best stock market months. Thanks to vaccine announcements, but also to the announcement of the election of Joe Biden to the U.S. presidency, although Donald Trump has still not conceded defeat. The bursts of "peripheral" indices are not enough to catch up with the lead accumulated in 2020 by Wall Street, even if meticulous observers may argue that the outperformance corrected for currency effects is less important, or that other markets such as China and Denmark are also showing very good results.
This morning, a new study shows that protection against reinfection appears to last at least eight months. Will this make enough noise to cover the deteriorating health situation in the United States?
In other news, the United Kingdom and Canada sign a post-Brexit business continuity agreement, the United States has listed 89 companies linked to the Chinese army to which American companies will no longer be allowed to export. Anthony Blinken will be Joe Biden's Secretary of State. The Japanese stock exchange is closed for a holiday.
PMI indicators are back today, with November's advanced ("flash") readings for the major economies, including France, Germany, the euro zone and the United States.